New Insights on Septoplasty versus Nasal Drops for Deviated Septum
Researchers from Newcastle University in Britain report that surgery to correct a crooked nasal septum improves breathing more reliably than relying on nasal drops. Their findings appear in the British Medical Journal (BMJ), one of the leading sources in medical research (BMJ, 2024).
A deviated septum means one nasal passage is smaller than the other, which can hinder airflow and cause discomfort during sleep or exercise. Many people turn to vasoconstrictor nasal drops to restore easier breathing through both nostrils. These drops can provide quick relief, but the quality and durability of that relief vary from person to person (BMJ study).
Aside from drops, there is a surgical option called septoplasty, which straightens the septum. The Newcastle study set out to determine whether septoplasty offers advantages over regular nasal spray treatment for those with nasal obstruction linked to septal deviation.
In the trial, 378 adults experiencing nasal congestion due to a deviated septum participated. They were randomly assigned to receive either septoplasty or nasal spray therapy. The goal was to compare breathing performance and overall well-being after an extended period on both approaches (BMJ trial description).
Six months after starting treatment, participants completed the Sinonasal Outcome Test (SNOT-22), a questionnaire measuring difficulties in nasal breathing and the discomfort caused by these problems. The results indicated that those who underwent septoplasty achieved better breathing function and a higher quality of life compared with the drug treatment group (BMJ study results).
The authors noted that ear, nose, and throat specialists could consider septoplasty more often as a treatment option for patients with persistent nasal obstruction due to septal deviation. The procedure tends to have a favorable safety profile and can reduce the need for ongoing spray use and its side effects (BMJ authors’ summary).
Previously popular nasal decongestant sprays were found to be ineffective for long-term relief in many cases. This research adds to the evidence base guiding clinicians to tailor treatment plans based on objective outcomes and patient preferences, rather than relying solely on symptomatic relief from sprays (BMJ commentary).
In summary, for those with a deviated septum and chronic breathing difficulties, septoplasty offers a durable improvement in airflow and life quality, while nasal drops may provide short-term relief but often require ongoing use. The study underscores the importance of personalized care and shared decision-making between patients and otolaryngologists, with careful consideration of the potential benefits and risks of surgery versus continued medical therapy (BMJ citation).